CITI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 8.040
AS - Asia 3.481
EU - Europa 3.035
SA - Sud America 521
Continente sconosciuto - Info sul continente non disponibili 425
AF - Africa 166
OC - Oceania 4
Totale 15.672
Nazione #
US - Stati Uniti d'America 7.831
IT - Italia 1.424
SG - Singapore 1.072
CN - Cina 954
HK - Hong Kong 548
BR - Brasile 419
VN - Vietnam 411
SE - Svezia 400
DE - Germania 284
BG - Bulgaria 165
FR - Francia 157
GB - Regno Unito 134
CA - Canada 125
FI - Finlandia 102
IN - India 84
AT - Austria 81
JP - Giappone 76
RU - Federazione Russa 72
KR - Corea 68
TR - Turchia 66
CI - Costa d'Avorio 56
PL - Polonia 50
NL - Olanda 45
BD - Bangladesh 39
MX - Messico 39
AR - Argentina 36
ZA - Sudafrica 32
IQ - Iraq 30
CH - Svizzera 22
SA - Arabia Saudita 20
EC - Ecuador 19
BE - Belgio 18
KE - Kenya 16
SN - Senegal 15
ID - Indonesia 14
UZ - Uzbekistan 14
CO - Colombia 12
UA - Ucraina 12
VE - Venezuela 12
ES - Italia 11
GR - Grecia 11
NG - Nigeria 10
PK - Pakistan 10
EU - Europa 9
TN - Tunisia 9
HU - Ungheria 8
JM - Giamaica 8
CZ - Repubblica Ceca 7
EG - Egitto 7
MA - Marocco 7
CR - Costa Rica 6
DK - Danimarca 6
DZ - Algeria 6
IL - Israele 6
JO - Giordania 6
PS - Palestinian Territory 6
TW - Taiwan 6
BO - Bolivia 5
HN - Honduras 5
LT - Lituania 5
MY - Malesia 5
NI - Nicaragua 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CL - Cile 4
GT - Guatemala 4
NP - Nepal 4
RO - Romania 4
AU - Australia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IR - Iran 3
KZ - Kazakistan 3
LV - Lettonia 3
SV - El Salvador 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
ET - Etiopia 2
IE - Irlanda 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
SY - Repubblica araba siriana 2
AO - Angola 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
Totale 15.241
Città #
Ashburn 696
Singapore 588
Hong Kong 533
San Jose 478
Fairfield 457
Serra 384
Santa Clara 373
Dallas 366
Woodbridge 352
Chandler 310
Houston 260
Seattle 208
Beijing 199
Ann Arbor 197
Council Bluffs 194
Wilmington 167
Sofia 164
Shanghai 162
Milan 150
Los Angeles 138
New York 133
Cambridge 129
Boardman 122
Chicago 116
Hefei 99
Hanoi 89
Ho Chi Minh City 86
Pisa 84
Munich 79
Princeton 79
Vienna 73
Florence 72
Lawrence 66
Tokyo 65
Rome 62
Seoul 62
Lauterbourg 60
Atlanta 59
Ottawa 59
Frankfurt am Main 58
London 58
Medford 57
Abidjan 56
Helsinki 43
Buffalo 42
Dong Ket 42
São Paulo 42
Warsaw 42
Des Moines 39
Orem 34
Istanbul 30
Nanjing 30
Redondo Beach 28
Salt Lake City 26
Turku 24
Phoenix 23
Lucca 22
Marseille 22
Johannesburg 21
Dearborn 20
Livorno 20
Da Nang 19
Nuremberg 19
San Diego 19
Naples 18
Washington 18
Zurich 18
Boulder 17
Grafing 17
Montreal 17
Toronto 17
Brooklyn 16
Elk Grove Village 16
Izmir 16
Lappeenranta 16
Dakar 15
Paris 15
San Francisco 15
Amsterdam 14
Brussels 14
Quanzhou 14
Baltimore 13
Bremen 13
Denver 13
Fuzhou 13
Mumbai 13
Redwood City 13
The Dalles 13
Guangzhou 12
Memphis 12
Mexico City 12
Tianjin 12
Boston 11
Düsseldorf 11
Nanchang 11
Napoli 11
Ogden 11
Tashkent 11
Baghdad 10
Haiphong 10
Totale 9.304
Nome #
Anti-Inflammatory and Vasorelaxant Effects Induced by an Aqueous Aged Black Garlic Extract Supplemented with Vitamins D, C, and B12 on Cardiovascular System 659
Metformin conjugates and therapeutic use thereof 392
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 384
Nutraceutical Features of the Phycobiliprotein C-Phycocyanin: Evidence from Arthrospira platensis (Spirulina) 381
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 311
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 301
Association of Myo-Inositol and Microlipodispersed Magnesium in Androgen-Dependent Dermatological Diseases: A Retrospective Study 293
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 263
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 256
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 244
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 242
Design, synthesis and biological evaluation of new H2S-releasing rivastigmine derivatives as neuroprotective molecules 236
Memantine prodrug as a new agent for alzheimer’s disease 231
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 229
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 226
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors 221
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 218
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives 217
D -Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase 214
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC 211
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 206
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 205
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 202
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 197
Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug 190
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer 183
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro 181
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 181
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 175
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 174
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 173
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma 172
Ex vivo and in vivo study of sucrosomial® iron intestinal absorption and bioavailability 169
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 165
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 156
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 155
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 155
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 151
The role of hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury 151
A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions 149
Pathophysiological role of mitochondrial potassium channels and their modulation by drugs 147
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? 147
Simulated Mars Gravity Impairs Intestinal Epithelial Barrier Integrity via Selective Modulation of Tight Junction Components 147
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines 145
null 142
New Synthetic Analogues of Natural Polyphenols as Sirtuin 1-Activating Compounds 140
KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA 137
Anomalous Kv7 channel activity in human malignant hyperthermia syndrome unmasks a key role for H2S and persulfidation in skeletal muscle 135
Role of hydrogen sulfide in endothelial dysfunction: Pathophysiology and therapeutic approaches 135
Sirtuin 1-activating derivatives belonging to the anilinopyridine class displaying in vivo cardioprotective activities 132
Mercaptopyruvate acts as endogenous vasodilator independently of 3-mercaptopyruvate sulfurtransferase activity 132
Cardiovascular benefits of Eruca sativa mill. Defatted seed meal extract: Potential role of hydrogen sulfide 132
Development of an adipocyte differentiation protocol using 3T3-L1 cells for the investigation of the browning process: identification of the PPAR-γ agonist rosiglitazone as a browning reference drug 131
Simulated Mars Gravity Impairs Intestinal Barrier Integrity: Protective Effects of Sumac 130
Organic Isothiocyanates as Hydrogen Sulfide Donors 129
Iminothioethers As A Novel Class Of H2s-Donor: Gasotransmitter Release And Vascular Effects 127
Vascular effects of H2S-donors: Fluorimetric detection of H2S generation and ion channel activation in human aortic smooth muscle cells 125
Searching for novel hydrogen sulfide donors: The vascular effects of two thiourea derivatives 124
Advances in Technologies for Highly Active Omega-3 Fatty Acids from Krill Oil: Clinical Applications 124
KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA 123
Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma 123
Role of hydrogen sulfide in cardiovascular ageing 120
In Vitro Models of Diabetes: Focus on Diabetic Retinopathy 120
Plants and Mushrooms as Possible New Sources of H2S Releasing Sulfur Compounds 118
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H2S Donors 117
null 113
New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways 107
Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches 107
The novel H2S donor 4-carboxy-phenyl isothiocyanate inhibits mast cell degranulation and renin release by decreasing intracellular calcium 105
Natural organo-sulfur compounds inhibit RBL-2H3 mast cell degranulation 104
Pharmacological evaluation of aryl-isothiocyanates as original H2S-donor derivatives: H2S-release and vascular effects 104
Hybrids between H2S-donors and betamethasone 17-valerate or triamcinolone acetonide inhibit mast cell degranulation and promote hyperpolarization of bronchial smooth muscle cells 102
null 100
Influence of Polyphenols on Adipose Tissue: Sirtuins as Pivotal Players in the Browning Process 99
DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer. 99
null 98
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 98
5α-dihydrotestosterone abrogates sex bias in asthma like features in the mouse 97
The h2 s-donor erucin exhibits protective effects against vascular inflammation in human endothelial and smooth muscle cells 96
Should CYP2D6 be genotyped when treating with tamoxifen? [Letter in reply] 95
Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2S donors in COVID-19 therapy 94
null 92
Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial 92
Development of In Vitro Corneal Models: Opportunity for Pharmacological Testing 92
Isothiocyanate-Corticosteroid Conjugates against asthma: Unity makes strength 90
Using hydrogen sulfide to design and develop drugs 90
Synthesis and biological evaluation of N–O heterobicyclic ring systems derived from 1,2-dihydropyridines as novel TRPA1 activators: implication in GLP-1 release and neuroprotection 86
Recent Advancements in Production and Extraction Methods of Phycobiliprotein C-phycocyanin by Arthrospira (Spirulina) platensis: A Mini Review 79
Hydrogen sulfide: The hidden player of isothiocyanates pharmacology 79
Should CYP2D6 be genotyped when treating with tamoxifen? 79
Pharmacological evaluation of innovative eye drop formulations containing TS-polysaccaride, hyaluronic acid and glycyrrhizin for irritative ocular diseases using in vitro reconstituted human corneal epithelium model 71
Regulation of blood pressure by natural sulfur compounds: Focus on their mechanisms of action 68
Potential Effects of Natural H2 S-Donors in Hypertension Management 68
Glucoraphanin Increases Intracellular Hydrogen Sulfide (H2S) Levels and Stimulates Osteogenic Differentiation in Human Mesenchymal Stromal Cell 62
null 60
Recent efforts in drug discovery on vascular inflammation and consequent atherosclerosis 60
Real-World Pilot Evaluation of a Novel Bioavailable Berberine Formulation (ToBeRock®) in Subjects with Impaired Fasting Glucose Through Pharmacy-Based Retrospective Study 59
Glucotropaeolin-enriched Lepidium sativum L. extract as a novel phytotherapy for tendinopathy: mechanistic insights into pain modulation 57
null 48
Naturally Occurring H2S-Donors in Vascular Diseases 47
Totale 15.498
Categoria #
all - tutte 42.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022748 0 24 17 22 126 135 25 34 47 39 67 212
2022/20231.272 149 179 98 80 125 162 12 80 245 15 74 53
2023/2024762 55 79 87 37 99 131 55 28 7 22 46 116
2024/20253.038 46 94 32 149 241 326 231 140 264 445 475 595
2025/20264.179 207 474 409 383 365 324 688 199 330 433 176 191
2026/20272.089 614 1.475 0 0 0 0 0 0 0 0 0 0
Totale 15.672